ArticleJournal of cheminformatics2026
Deep learning for assay nuisance compound detection using a gated co-attention graph embedding model (CAGE-Fusion).
Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In drug discovery, nuisance compounds are chemicals that interfere with biochemical or cell-based assays, often generating misleading signals unrelated to true activity. These molecules operate through diverse, context-dependent mechanisms, ranging from colloidal aggregation to covalent reactivity. They are often referred to as Pan-Assay Interference Compounds (PAINS), signal interferers, or frequent hitters, depending on their mode of action, and they lead to costly false positives and resource misallocation. They are difficult to distinguish from genuine pharmacological activity using rigid substructure filters. Although deep learning has emerged as a powerful alternative, most existing architectures process molecular graphs or SMILES sequences in isolation. We introduce CAGE-Fusion (Co-Attention Graph Embedding Fusion), a multimodal framework that employs a gated co-attention mechanism to enforce bidirectional information exchange between graph-based and sequence-based encoders. This architecture enables the iterative refinement of atom and token embeddings, yielding a chemically coherent representation that captures cross-modal dependencies. CAGE-Fusion demonstrates competitive predictive performance across several MoleculeNet benchmarks and achieves a macro-averaged PR-AUC of 0.73 and ROC-AUC of 0.94 on a comprehensive nuisance compound classification task. Beyond prediction, the model visualizes attention-weighted regions that contribute to a classification decision.Scientific contributionWe present CAGE-Fusion, a gated co-attention architecture that enables bidirectional information exchange between graph-based encoders and SMILES representations to learn cross-modal molecular embeddings. We evaluate the framework on standardized molecular property benchmarks and apply it in a focused case study on assay nuisance compound detection across four nuisance categories: aggregation, luciferase inhibition, reactivity, and promiscuity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.